Why Augmented Reality Matters for Healthcare: Augmedics President, Tim Murawski
Tim Murawski serves as the president for Augmedics, a Chicago-area company developing medical devices to bring augmented reality technology to spinal surgery. He has more than 20 years of business experience and previously served as vice president of business development for Inspirata Inc. and Palomar Medical Technologies Inc. After successfully launching a laser sterilization product that was the first of its kind, Tim Murawski was appointed director of global sales at Otonomy Inc.
Tim Murawski led the global commercialization of Otonomy’s lead drug candidate, OTIPRIO, a first-in-class therapy for otitis media (ear infections), in the European Union and Latin America. During his time at Otonomy, he also led the establishment of a team to promote OTIPRIO in Japan and expand the sales efforts of OTIPRIO and another product, OTIPRIO SYNDROME, in Europe, Russia, Latin America, and the Asia Pacific. Tim Murawski has played a significant role in creating and commercializing groundbreaking surgical robotics technology.
Salesman Tim Murawski was most recently the President and Chief Commercial Officer of Mazor Robotics. It is a medical device company that commercialized the Mazor X™ system, a robotic platform for advanced spine surgery. Before joining Mazor Robotics in 2013, he served as the Vice President of Global Sales and Marketing for Accuray Incorporated, a global leader in precision radiation oncology.
The serial businessman Tim Murawski commenced as a development and research technician at Baxter Healthcare Corporation. Before joining Augmedics in 2000, he served in multiple leadership roles for medical device companies, including Intuitive Surgical. He has been an executive at the intersection of the healthcare and technology industries for over 20 years, working with companies to grow and improve existing markets and new verticals, such as health systems, insurance, medical equipment, and health apps.